<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0137282</article-id>
<article-id pub-id-type="publisher-id">PONE-D-15-17094</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Morpho-Functional 1H-MRI of the Lung in COPD: Short-Term Test-Retest Reliability</article-title>
<alt-title alt-title-type="running-head">Test-Retest Reliability of Lung MRI in COPD</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Jobst</surname>
<given-names>Bertram J.</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
<xref rid="aff003" ref-type="aff"><sup>3</sup></xref>
<xref rid="cor001" ref-type="corresp">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Wielpütz</surname>
<given-names>Mark O.</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
<xref rid="aff003" ref-type="aff"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Triphan</surname>
<given-names>Simon M. F.</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
<xref rid="aff004" ref-type="aff"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Anjorin</surname>
<given-names>Angela</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
<xref rid="aff003" ref-type="aff"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Ley-Zaporozhan</surname>
<given-names>Julia</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
<xref rid="aff005" ref-type="aff"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kauczor</surname>
<given-names>Hans-Ulrich</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
<xref rid="aff003" ref-type="aff"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Biederer</surname>
<given-names>Jürgen</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
<xref rid="aff006" ref-type="aff"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Ley</surname>
<given-names>Sebastian</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
<xref rid="aff007" ref-type="aff"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Sedlaczek</surname>
<given-names>Oliver</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
<xref rid="aff003" ref-type="aff"><sup>3</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Diagnostic &amp; Interventional Radiology, University Hospital of Heidelberg, Heidelberg, Germany</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Translational Lung Research Center Heidelberg (TLRC), Member of the German Lung Research Center (DZL), Heidelberg, Germany</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik at University of Heidelberg, Heidelberg, Germany</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Research Center Magnetic Resonance Bavaria (MRB), Würzburg, Germany</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>Institute for Clinical Radiology, Ludwig-Maximilians-University Hospital Munich, Munich, Germany</addr-line></aff>
<aff id="aff006"><label>6</label> <addr-line>Radiologie Darmstadt, Department of Radiology, County Hospital Gross-Gerau, Gross-Gerau, Germany</addr-line></aff>
<aff id="aff007"><label>7</label> <addr-line>Department of Diagnostic &amp; Interventional Radiology, Surgical Hospital Dr. Rinecker, Munich, Germany</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Sznitman</surname>
<given-names>Josué</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Technion—Israel Institute of Technology, ISRAEL</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con" id="contrib001">
<p>Conceived and designed the experiments: BJJ MOW SMFT AA JLZ HUK JB SL OS. Performed the experiments: BJJ MOW SMFT AA JLZ HUK JB SL OS. Analyzed the data: BJJ MOW SMFT AA JLZ HUK JB SL OS. Contributed reagents/materials/analysis tools: BJJ MOW SMFT AA JLZ HUK JB SL OS. Wrote the paper: BJJ MOW SMFT AA JLZ HUK JB SL OS.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">bertram.jobst@med.uni-heidelberg.de</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>1</day>
<month>9</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<volume>10</volume>
<issue>9</issue>
<elocation-id>e0137282</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>4</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>8</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-year>2015</copyright-year>
<copyright-holder>Jobst et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0137282" xlink:type="simple"/>
<abstract>
<sec id="sec001">
<title>Purpose</title>
<p>Non-invasive end-points for interventional trials and tailored treatment regimes in chronic obstructive pulmonary disease (COPD) for monitoring regionally different manifestations of lung disease instead of global assessment of lung function with spirometry would be valuable. Proton nuclear magnetic resonance imaging (1H-MRI) allows for a radiation-free assessment of regional structure and function. The aim of this study was to evaluate the short-term reproducibility of a comprehensive morpho-functional lung MRI protocol in COPD.</p>
</sec>
<sec id="sec002">
<title>Materials and Methods</title>
<p>20 prospectively enrolled COPD patients (GOLD I-IV) underwent 1H-MRI of the lung at 1.5T on two consecutive days, including sequences for morphology, 4D contrast-enhanced perfusion, and respiratory mechanics. Image quality and COPD-related morphological and functional changes were evaluated in consensus by three chest radiologists using a dedicated MRI-based visual scoring system. Test-retest reliability was calculated per each individual lung lobe for the extent of large airway (bronchiectasis, wall thickening, mucus plugging) and small airway abnormalities (tree in bud, peripheral bronchiectasis, mucus plugging), consolidations, nodules, parenchymal defects and perfusion defects. The presence of tracheal narrowing, dystelectasis, pleural effusion, pulmonary trunk ectasia, right ventricular enlargement and, finally, motion patterns of diaphragma and chest wall were addressed.</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>Median global scores [10(Q1:8.00;Q3:16.00) vs.11(Q1:6.00;Q3:15.00)] as well as category subscores were similar between both timepoints, and kappa statistics indicated “almost perfect” global agreement (ĸ = 0.86, 95%CI = 0.81–0.91). Most subscores showed at least “substantial” agreement of MRI1 and MRI2 (ĸ = 0.64–1.00), whereas the agreement for the diagnosis of dystelectasis/effusion (ĸ = 0.42, 95%CI = 0.00–0.93) was “moderate” and of tracheal abnormalities (ĸ = 0.21, 95%CI = 0.00–0.75) “fair”. Most MRI acquisitions showed at least diagnostic quality at MRI1 (276 of 278) and MRI2 (259 of 264).</p>
</sec>
<sec id="sec004">
<title>Conclusion</title>
<p>Morpho-functional 1H-MRI can be obtained with reproducible image quality and high short-term test-retest reliability for COPD-related morphological and functional changes of the lung. This underlines its potential value for the monitoring of regional lung characteristics in COPD trials.</p>
</sec>
</abstract>
<funding-group>
<funding-statement>This work has been supported by the Competence Network on Asthma/COPD (ASCONET) through a grant from the Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF) of the federal government of Germany (01GI0870, <ext-link ext-link-type="uri" xlink:href="http://www.bmbf.de/en" xlink:type="simple">www.bmbf.de/en</ext-link>). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflict of interest with regard to the study at hand.</funding-statement>
</funding-group>
<counts>
<fig-count count="4"/>
<table-count count="5"/>
<page-count count="15"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability" xlink:type="simple">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>Introduction</title>
<p>At present, pulmonary function testing is the method of choice for initial diagnosis and follow-up of chronic obstructive pulmonary disease [<xref rid="pone.0137282.ref001" ref-type="bibr">1</xref>]. As manifestations of the disease are typically inhomogeneous with different degrees of involvement throughout the lung and as compensation of functional impairment of the diseased areas by intact portions of the organ is relevant, global parameters from PFT such as FEV1% may not be optimally suitable for monitoring disease activity and the efficacy of treatment [<xref rid="pone.0137282.ref001" ref-type="bibr">1</xref>]. Due to the evolving spectrum of therapeutic options for COPD patients, requirements related to the monitoring of lung structure and function in interventional COPD trials are increased. Alternative endpoints which reflect changes in regional lung structure and function would be most welcome. Many requirements in this field are met by computed tomography (CT), which is the current modality of choice for in vivo imaging of COPD [<xref rid="pone.0137282.ref002" ref-type="bibr">2</xref>], but longitudinal follow-up with CT cannot be achieved without excess radiation exposure [<xref rid="pone.0137282.ref003" ref-type="bibr">3</xref>]. In recent years proton MRI has emerged as a promising new option for the radiation-free characterization and follow-up of COPD [<xref rid="pone.0137282.ref004" ref-type="bibr">4</xref>–<xref rid="pone.0137282.ref006" ref-type="bibr">6</xref>]. Current MRI techniques comprise morphological as well as functional sequences combining reasonable diagnostic accuracy with relatively easy handling [<xref rid="pone.0137282.ref007" ref-type="bibr">7</xref>]. In this context, MRI-based monitoring of patients with cystic fibrosis demonstrated the ability of MRI to depict alterations of lung structure and perfusion, and detect the response to therapy in patients with exacerbation [<xref rid="pone.0137282.ref008" ref-type="bibr">8</xref>]. MRI perfusion imaging has already been shown to be able to distinguish patients with mild COPD from healthy controls [<xref rid="pone.0137282.ref009" ref-type="bibr">9</xref>], and to correlate well with both FEV1% [<xref rid="pone.0137282.ref010" ref-type="bibr">10</xref>] and diffusing capacity [<xref rid="pone.0137282.ref011" ref-type="bibr">11</xref>]. But the applicability of imaging procedures in the context of patient monitoring not only depends on diagnostic accuracy and easy handling, but also on reproducibility. Test-retest reliability of imaging-derived biomarkers such as scores for morphologic changes and perfusion needs to be assessed before their use as trial endpoints in the scientific or clinical context. The aim of this study was to shape a streamlined MRI protocol based on commercially (“out of the box”) available sequences which provides a comprehensive assessment of both morphological and functional lung characteristics of COPD patients within a single study and evaluate its short-term test-retest reliability. For this purpose, 20 COPD patients of different GOLD stages underwent MRI on two consecutive days, and all exams were assessed using an established MRI score for airways disease.</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec007">
<title>Ethics statement</title>
<p>This prospective study was approved by the Institutional Review Board of the Medical Faculty of the University of Heidelberg, Germany. The work was carried out in accordance with the Declaration of Helsinki (The Code of Ethics of the World Medical Association). Prior to participation in the study, all subjects gave their written informed consent.</p>
</sec>
<sec id="sec008">
<title>Study design and patient characteristics</title>
<p>N = 20 patients [median age 66 (Q1:59; Q3:74) years] diagnosed with COPD and different disease severity according to the GOLD criteria [<xref rid="pone.0137282.ref012" ref-type="bibr">12</xref>] were enrolled. The cohort included n = 10 patients with mild COPD (GOLD stages I-II) recruited from an outpatient clinic, and n = 10 patients with severe COPD (GOLD stages III-IV) from a specialized chest clinic (<xref rid="pone.0137282.t001" ref-type="table">Table 1</xref>). Each patient prospectively underwent an identical lung MRI exam on two consecutive days (MRI1 / MRI2).</p>
<table-wrap id="pone.0137282.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0137282.t001</object-id>
<label>Table 1</label> <caption><title>Patient characteristics.</title> <p>10 patients with mild COPD (GOLD stages I &amp; II) and 10 patients with severe COPD (GOLD stages III &amp; IV) were enrolled into the study.</p></caption>
<alternatives>
<graphic id="pone.0137282.t001g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0137282.t001" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="1" colspan="1"/>
<th align="center" rowspan="1" colspan="1">GOLD I &amp; II</th>
<th align="center" rowspan="1" colspan="1">GOLD III &amp; IV</th>
<th align="center" rowspan="1" colspan="1">Global</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">N</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">20</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Male / Female (n)</td>
<td align="center" rowspan="1" colspan="1">9/1</td>
<td align="center" rowspan="1" colspan="1">9/1</td>
<td align="center" rowspan="1" colspan="1">18/2</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Min age (y)</td>
<td align="center" rowspan="1" colspan="1">49</td>
<td align="center" rowspan="1" colspan="1">60</td>
<td align="center" rowspan="1" colspan="1">49</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Max age (y)</td>
<td align="center" rowspan="1" colspan="1">77</td>
<td align="center" rowspan="1" colspan="1">79</td>
<td align="center" rowspan="1" colspan="1">79</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Median age (y)</td>
<td align="center" rowspan="1" colspan="1">59 (Q1:55; Q3:70)</td>
<td align="center" rowspan="1" colspan="1">69 (Q1:63; Q3:74)</td>
<td align="center" rowspan="1" colspan="1">66 (Q1:59; Q3:74)</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
</sec>
<sec id="sec009">
<title>Imaging</title>
<p>The MRI protocol was specifically tailored to the demands of structural and functional alterations of the pulmonary parenchyma, vasculature and airways using a clinical 1.5T scanner (Magnetom Avanto, Siemens Medical Solutions, Erlangen, Germany) and current protocol recommendations based on commercially available sequences [<xref rid="pone.0137282.ref007" ref-type="bibr">7</xref>]. Structural aspects were addressed with the following sequences in coronal and transverse orientation: Volume interpolated gradient echo (GRE, VIBE), acquired in inspiratory breath-holds, before and after contrast application (incl. fat saturation), fat-saturated, free-breathing periodically rotated overlapping parallel lines with enhanced reconstruction (BLADE), acquired in free breathing and triggered to the expiratory phase, half-fourier acquisition single-shot turbo spin-echo (HASTE) in inspiratory breath-holds, and balanced steady-state free precession (bSSFP, TrueFISP) during free breathing. Breath-holding times of most morphological sequences were kept below 25 seconds, except VIBEs that include fat saturation pulses. Dynamic contrast enhanced (DCE) first pass perfusion MRI was based on a three-dimensional GRE view sharing sequence with stochastic trajectories (TWIST) at high temporal resolution (1.47 s/volume) during inspiratory breath-hold and contrast bolus injection by a power injector (0.05 mmol/kg Gd-DTPA, Magnevist, Bayer Schering Pharma AG, Berlin, German) at a rate of 5 ml/s followed by a bolus chaser of 30 ml NaCl). The acquisition comprised 24 consecutive measurements, covering a time span of max. 37s. The initial passage of the contrast bolus through the pulmonary vasculature required a breath-holding time of 15–25 seconds. Patients were advised to hold breath as long as possible and then breathe shallowly. Subtraction images in coronal orientation with a spatial resolution of 1.95 x 1.95 mm in-plane and 5 mm slice thickness were used for visual analysis. For the evaluation of respiratory mechanics, two-dimensional time-resolved TrueFISP (dynamic TrueFISP) sequences were acquired during maximum inspiration and expiration in coronal and angulated sagittal orientation, each through the center of the right and left diaphragm. In total, image acquisition took on average 30 minutes. Details on the applied sequence parameters are provided in <xref rid="pone.0137282.t002" ref-type="table">Table 2</xref>.</p>
<table-wrap id="pone.0137282.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0137282.t002</object-id>
<label>Table 2</label> <caption><title>MRI protocol and sequence parameters.</title></caption>
<alternatives>
<graphic id="pone.0137282.t002g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0137282.t002" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="1" colspan="1">sequence</th>
<th align="left" rowspan="1" colspan="1">mode</th>
<th align="left" rowspan="1" colspan="1">orien-tation</th>
<th align="left" rowspan="1" colspan="1">breathmode</th>
<th align="left" rowspan="1" colspan="1">contrast medium</th>
<th align="left" rowspan="1" colspan="1">TR (ms)</th>
<th align="left" rowspan="1" colspan="1">TE (ms)</th>
<th align="left" rowspan="1" colspan="1">FoV (mm<sup>2</sup>)</th>
<th align="left" rowspan="1" colspan="1">slice thickn. (mm)</th>
<th align="left" rowspan="1" colspan="1">voxel size (mm<sup>2</sup>)</th>
<th align="left" rowspan="1" colspan="1">matrix</th>
<th align="left" rowspan="1" colspan="1">scan time (min:s)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">TrueFISP</td>
<td align="left" rowspan="1" colspan="1">2D</td>
<td align="left" rowspan="1" colspan="1">cor</td>
<td align="left" rowspan="1" colspan="1">free</td>
<td align="left" rowspan="1" colspan="1">native</td>
<td align="left" rowspan="1" colspan="1">339.29</td>
<td align="left" rowspan="1" colspan="1">1.16</td>
<td align="left" rowspan="1" colspan="1">500×500</td>
<td align="left" rowspan="1" colspan="1">4.0</td>
<td align="left" rowspan="1" colspan="1">19.5×1.95</td>
<td align="left" rowspan="1" colspan="1">256×256</td>
<td align="left" rowspan="1" colspan="1">0:43</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">TrueFISP</td>
<td align="left" rowspan="1" colspan="1">2D</td>
<td align="left" rowspan="1" colspan="1">tra</td>
<td align="left" rowspan="1" colspan="1">free</td>
<td align="left" rowspan="1" colspan="1">native</td>
<td align="left" rowspan="1" colspan="1">290.30</td>
<td align="left" rowspan="1" colspan="1">1.16</td>
<td align="left" rowspan="1" colspan="1">440×358</td>
<td align="left" rowspan="1" colspan="1">4.0</td>
<td align="left" rowspan="1" colspan="1">1.95×1.95</td>
<td align="left" rowspan="1" colspan="1">256×208</td>
<td align="left" rowspan="1" colspan="1">0:37</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">VIBE</td>
<td align="left" rowspan="1" colspan="1">3D</td>
<td align="left" rowspan="1" colspan="1">cor</td>
<td align="left" rowspan="1" colspan="1">insp</td>
<td align="left" rowspan="1" colspan="1">native</td>
<td align="left" rowspan="1" colspan="1">3.20</td>
<td align="left" rowspan="1" colspan="1">1.14</td>
<td align="left" rowspan="1" colspan="1">500×500</td>
<td align="left" rowspan="1" colspan="1">4.0</td>
<td align="left" rowspan="1" colspan="1">0.98×0.98</td>
<td align="left" rowspan="1" colspan="1">256×256</td>
<td align="left" rowspan="1" colspan="1">0:20</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">VIBE</td>
<td align="left" rowspan="1" colspan="1">3D</td>
<td align="left" rowspan="1" colspan="1">tra</td>
<td align="left" rowspan="1" colspan="1">insp</td>
<td align="left" rowspan="1" colspan="1">native</td>
<td align="left" rowspan="1" colspan="1">3.46</td>
<td align="left" rowspan="1" colspan="1">1.18</td>
<td align="left" rowspan="1" colspan="1">400×350</td>
<td align="left" rowspan="1" colspan="1">4.0</td>
<td align="left" rowspan="1" colspan="1">1.56×1.56</td>
<td align="left" rowspan="1" colspan="1">256×224</td>
<td align="left" rowspan="1" colspan="1">0:23</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">HASTE</td>
<td align="left" rowspan="1" colspan="1">2D</td>
<td align="left" rowspan="1" colspan="1">cor</td>
<td align="left" rowspan="1" colspan="1">insp</td>
<td align="left" rowspan="1" colspan="1">native</td>
<td align="left" rowspan="1" colspan="1">600</td>
<td align="left" rowspan="1" colspan="1">32.00</td>
<td align="left" rowspan="1" colspan="1">500×500</td>
<td align="left" rowspan="1" colspan="1">6.0</td>
<td align="left" rowspan="1" colspan="1">0.98×0.98</td>
<td align="left" rowspan="1" colspan="1">512×512</td>
<td align="left" rowspan="1" colspan="1">0:13×2</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">HASTE</td>
<td align="left" rowspan="1" colspan="1">2D</td>
<td align="left" rowspan="1" colspan="1">tra</td>
<td align="left" rowspan="1" colspan="1">insp</td>
<td align="left" rowspan="1" colspan="1">native</td>
<td align="left" rowspan="1" colspan="1">571</td>
<td align="left" rowspan="1" colspan="1">42.00</td>
<td align="left" rowspan="1" colspan="1">400×350</td>
<td align="left" rowspan="1" colspan="1">6.0</td>
<td align="left" rowspan="1" colspan="1">1.56×1.56</td>
<td align="left" rowspan="1" colspan="1">256×224</td>
<td align="left" rowspan="1" colspan="1">0:18</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BLADE</td>
<td align="left" rowspan="1" colspan="1">2D</td>
<td align="left" rowspan="1" colspan="1">cor</td>
<td align="left" rowspan="1" colspan="1">trig</td>
<td align="left" rowspan="1" colspan="1">native</td>
<td align="left" rowspan="1" colspan="1">6300.25</td>
<td align="left" rowspan="1" colspan="1">83.00</td>
<td align="left" rowspan="1" colspan="1">500×500</td>
<td align="left" rowspan="1" colspan="1">4.0</td>
<td align="left" rowspan="1" colspan="1">1.56×1.56</td>
<td align="left" rowspan="1" colspan="1">320×320</td>
<td align="left" rowspan="1" colspan="1">2:49</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BLADE</td>
<td align="left" rowspan="1" colspan="1">2D</td>
<td align="left" rowspan="1" colspan="1">tra</td>
<td align="left" rowspan="1" colspan="1">trig</td>
<td align="left" rowspan="1" colspan="1">native</td>
<td align="left" rowspan="1" colspan="1">7048.25</td>
<td align="left" rowspan="1" colspan="1">83.00</td>
<td align="left" rowspan="1" colspan="1">500×500</td>
<td align="left" rowspan="1" colspan="1">4.0</td>
<td align="left" rowspan="1" colspan="1">1.56×1.56</td>
<td align="left" rowspan="1" colspan="1">320×320</td>
<td align="left" rowspan="1" colspan="1">3:42</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">TWIST</td>
<td align="left" rowspan="1" colspan="1">4D</td>
<td align="left" rowspan="1" colspan="1">cor</td>
<td align="left" rowspan="1" colspan="1">insp</td>
<td align="left" rowspan="1" colspan="1">dynamic</td>
<td align="left" rowspan="1" colspan="1">1.80</td>
<td align="left" rowspan="1" colspan="1">0.68</td>
<td align="left" rowspan="1" colspan="1">500×500</td>
<td align="left" rowspan="1" colspan="1">5.0</td>
<td align="left" rowspan="1" colspan="1">1.95×1.95</td>
<td align="left" rowspan="1" colspan="1">256×256</td>
<td align="left" rowspan="1" colspan="1">0:37</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">VIBE FatSat</td>
<td align="left" rowspan="1" colspan="1">3D</td>
<td align="left" rowspan="1" colspan="1">cor</td>
<td align="left" rowspan="1" colspan="1">insp</td>
<td align="left" rowspan="1" colspan="1">post-contrast</td>
<td align="left" rowspan="1" colspan="1">3.35</td>
<td align="left" rowspan="1" colspan="1">1.18</td>
<td align="left" rowspan="1" colspan="1">500×500</td>
<td align="left" rowspan="1" colspan="1">4.0</td>
<td align="left" rowspan="1" colspan="1">0.98×0.98</td>
<td align="left" rowspan="1" colspan="1">512×512</td>
<td align="left" rowspan="1" colspan="1">0:33</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">VIBE FatSat</td>
<td align="left" rowspan="1" colspan="1">3D</td>
<td align="left" rowspan="1" colspan="1">tra</td>
<td align="left" rowspan="1" colspan="1">insp</td>
<td align="left" rowspan="1" colspan="1">post-contrast</td>
<td align="left" rowspan="1" colspan="1">3.35</td>
<td align="left" rowspan="1" colspan="1">1.18</td>
<td align="left" rowspan="1" colspan="1">400×350</td>
<td align="left" rowspan="1" colspan="1">4.0</td>
<td align="left" rowspan="1" colspan="1">0.78×0.78</td>
<td align="left" rowspan="1" colspan="1">512×448</td>
<td align="left" rowspan="1" colspan="1">0:32</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">TrueFISP</td>
<td align="left" rowspan="1" colspan="1">2D+t</td>
<td align="left" rowspan="1" colspan="1">cor</td>
<td align="left" rowspan="1" colspan="1">forced</td>
<td align="left" rowspan="1" colspan="1">post-contrast</td>
<td align="left" rowspan="1" colspan="1">317.10</td>
<td align="left" rowspan="1" colspan="1">1.08</td>
<td align="left" rowspan="1" colspan="1">500×500</td>
<td align="left" rowspan="1" colspan="1">6.0</td>
<td align="left" rowspan="1" colspan="1">0.98×0.98</td>
<td align="left" rowspan="1" colspan="1">512×512</td>
<td align="left" rowspan="1" colspan="1">0:24</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">TrueFISP</td>
<td align="left" rowspan="1" colspan="1">2D+t</td>
<td align="left" rowspan="1" colspan="1">sag R</td>
<td align="left" rowspan="1" colspan="1">forced</td>
<td align="left" rowspan="1" colspan="1">post-contrast</td>
<td align="left" rowspan="1" colspan="1">317.10</td>
<td align="left" rowspan="1" colspan="1">1.11</td>
<td align="left" rowspan="1" colspan="1">450×450</td>
<td align="left" rowspan="1" colspan="1">6.0</td>
<td align="left" rowspan="1" colspan="1">0.88×0.88</td>
<td align="left" rowspan="1" colspan="1">512×512</td>
<td align="left" rowspan="1" colspan="1">0:25</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">TrueFISP</td>
<td align="left" rowspan="1" colspan="1">2D+t</td>
<td align="left" rowspan="1" colspan="1">sag L</td>
<td align="left" rowspan="1" colspan="1">forced</td>
<td align="left" rowspan="1" colspan="1">post-contrast</td>
<td align="left" rowspan="1" colspan="1">317.10</td>
<td align="left" rowspan="1" colspan="1">1.11</td>
<td align="left" rowspan="1" colspan="1">450×450</td>
<td align="left" rowspan="1" colspan="1">6.0</td>
<td align="left" rowspan="1" colspan="1">0.88×0.88</td>
<td align="left" rowspan="1" colspan="1">512×512</td>
<td align="left" rowspan="1" colspan="1">0:25</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>All sequences are acquired in 3D or 2D multi-slice modes and were accelerated using GRAPPA with a parallelization factor of 2. Breathing mode indicates <bold>free</bold> breathing, one or more breath-hold in <bold>insp</bold>iration or <bold>exp</bold>iration, expiration <bold>trig</bold>gered acquisition or dynamic acquisition during <bold>forced in</bold>- and <bold>exp</bold>iration.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec010">
<title>Image evaluation</title>
<p>MRI1 and MRI2 were evaluated employing a scoring system specifically reporting the extent and distribution of COPD-related abnormalities, which was a modification of a previously established MRI scoring system for airways disease [<xref rid="pone.0137282.ref008" ref-type="bibr">8</xref>,<xref rid="pone.0137282.ref013" ref-type="bibr">13</xref>]. The scoring system categorizes COPD-related abnormalities, and each category is rated with a 3-point scale of 0, 1 or 2 or a 2-point scale of 0 and 1 (max. score 98) in a lobe-based approach as described in the following:</p>
<sec id="sec011">
<title>Tracheal disease</title>
<p>For the diagnosis of tracheal disease, we considered conditions affecting the structure of the trachea or right and left stem bronchi such as collapse, stenosis, or saber sheath trachea. The rating of tracheal pathologies was mainly based on inspiratory VIBE, BLADE, and TrueFISP. The BLADE images were acquired during expiratory phase and thus provided complementary information to inspiratory VIBE images. Together, the previously mentioned sequences allowed for the visual evaluation of the tracheal cross-sectional area during the breathing cycle: 0 = absent, 1 = moderate (≤ 50% decrease in lumen area), 2 = severe (&gt; 50% decrease in lumen area).</p>
</sec>
<sec id="sec012">
<title>Bronchial disease</title>
<p>This category summarizes COPD-related pathologies with localisation in the lobar bronchi and segmental bronchi in a combined approach [<xref rid="pone.0137282.ref013" ref-type="bibr">13</xref>], i.e. bronchiectasis, bronchial wall thickening, stenosis, and bronchial mucus plugging with hyperintense intraluminal appearance on T2-weighted images. 0 = absent, 1 = ≤50% of lobe, 2 = &gt;50% of lobe.</p>
</sec>
<sec id="sec013">
<title>Small airway disease</title>
<p>Tree-in-bud appearance and peripheral bronchiectasis (visibility of bronchi within 2 cm from the pleural surface): 0 = absent, 1 = ≤50% of lobe, 2 = &gt;50% of lobe.</p>
</sec>
<sec id="sec014">
<title>Consolidations</title>
<p>Areas with an increase in parenchymal signal intensity &gt; 2.0 cm in diameter with possible presence of air bronchogram or contrast enhancement [<xref rid="pone.0137282.ref013" ref-type="bibr">13</xref>]: 0 = absent, 1 = ≤50% of lobe, 2 = &gt;50% of lobe.</p>
</sec>
<sec id="sec015">
<title>Nodules</title>
<p>0 = absent, 1 = &lt; 1.0 cm, 2 = ≥ 1.0 cm.</p>
</sec>
<sec id="sec016">
<title>Parenchymal defects</title>
<p>Areas of decrease in parenchymal signal intensity on inspiratory HASTE, VIBE, and/or post-contrast VIBE [<xref rid="pone.0137282.ref014" ref-type="bibr">14</xref>]: 0 = absent, 1 = ≤50% of lobe, 2 = &gt;50% of lobe.</p>
</sec>
<sec id="sec017">
<title>Perfusion defects</title>
<p>Areas of reduced or missing enhancement on subtracted peak perfusion maps. Other causes not related to airway disease or emphysema, in particular pulmonary embolism, infiltration and atelectasis, were excluded [<xref rid="pone.0137282.ref013" ref-type="bibr">13</xref>]: 0 = absent, 1 = ≤50% of lobe, 2 = &gt;50% of lobe.</p>
</sec>
<sec id="sec018">
<title>Perfusion defects due to collateral causes</title>
<p>Perfusion defects not related to airway disease (infiltration, atelectasis, pulmonary embolism): 0 = absent, 1 = ≤50% of lobe, 2 = &gt;50% of lobe.</p>
</sec>
<sec id="sec019">
<title>Impaired respiratory mechanics</title>
<p>Motion impairment of the chest wall and/or diaphragm such as diaphragmatic depression with / without paradoxical motion as published previously [<xref rid="pone.0137282.ref015" ref-type="bibr">15</xref>–<xref rid="pone.0137282.ref017" ref-type="bibr">17</xref>]. Different causes, in particular phrenic paralysis or atelectasis were excluded. The evaluation was performed for each hemithorax: 0 = absent, 1 = moderate impairment (diaphragmatic flattening, reduced or paradoxical motion of chest wall and/or diaphragm), 2 = severe impairment (diaphragmatic motion hardly visible).</p>
</sec>
<sec id="sec020">
<title>Impairment of respiratory mechanics due to collateral causes</title>
<p>Respiratory motion impairment as collateral finding (prevailing conditions which are not COPD-related, i.e. phrenic paralysis or atelectasis): 0 = absent, 1 = moderate impairment, 2 = severe impairment.</p>
</sec>
<sec id="sec021">
<title>Pulmonary trunk ectasia</title>
<p>0 = diameter PA &lt; 29 mm, 1 = diameter PA ≥ 29 mm [<xref rid="pone.0137282.ref018" ref-type="bibr">18</xref>].</p>
</sec>
<sec id="sec022">
<title>Right ventricular enlargement</title>
<p>Right ventricle (RV) to left ventricle ratio (LV), 0 = RV/LV ≤ 1.0, 1 = RV/LV &gt; 1.0 [<xref rid="pone.0137282.ref019" ref-type="bibr">19</xref>].</p>
</sec>
<sec id="sec023">
<title>Special findings</title>
<p>This category summarizes unspecific findings which are not met by other categories, such as parenchyma bands, dystelectasis, pleural effusion, pleurisy, pneumothorax, or pleural peels. Such special findings were analysed separately for the right and left hemithorax: 0 = absent, 1 = present.</p>
<p>All 39 MRI datasets were evaluated in consensus by three chest radiologists with 2–4 years of experience in pulmonary <sup>1</sup>H-MRI. MRI2 was assessed one week after MRI1. Every single observation was documented for further evaluation of test-retest reliability. Subscores were calculated for each category as the sum of each lobar score, and the global score was calculated as the sum of all category subscores. Image quality was rated in consensus for every single MRI sequence: 0 = excellent, 1 = reduced but diagnostic, 2 = not diagnostic.</p>
</sec>
</sec>
<sec id="sec024">
<title>Statistical analysis</title>
<p>Scores are given as median with interquartile range (Q1 to Q3). The test-retest reliability (MRI1 vs. MRI2) was assessed by weighted kappa with quadratic weighting [<xref rid="pone.0137282.ref020" ref-type="bibr">20</xref>] for ordinal variables and by Cohen´s kappa [<xref rid="pone.0137282.ref021" ref-type="bibr">21</xref>] for nominal variables. We employed the following levels of agreement: 0–0.20 = poor, 0.21–0.40 = fair, 0.41–0.60 = moderate, 0.61–0.80 = substantial, 0.81–1.00 = almost perfect [<xref rid="pone.0137282.ref022" ref-type="bibr">22</xref>]. Global sum scores and category subscores of test and retest were compared by Wilcoxon signed-rank test for skewed distributions and paired Student's t-test for normal distributions. Calculations were done using IBM SPSS statistics 22 (International Business Machines Corporation IBM, Armonk, NY, USA).</p>
</sec>
</sec>
<sec id="sec025" sec-type="results">
<title>Results</title>
<sec id="sec026">
<title>Technical feasibility and image quality</title>
<p>MRI1 could be completed in 18 of 20 patients, and partially completed in 2 of 20 patients who refused intravenous contrast application. MRI2 was rejected by 1 patient, and again 2 patients refused intravenous application of contrast media. The semiquantitative visual image evaluation did not exceed 20 minutes per dataset. Inspiratory HASTE, free-breathing TrueFISP, as well as dynamic TrueFISP during maximum inspiration and expiration demonstrated excellent image quality (score = 0) at MRI1 and MRI2. Image quality of other MRI sequences was also thoroughly reported as being diagnostic (score = 1) or excellent (score = 0) with few exceptions: post-contrast VIBE showed insufficient image quality due to respiratory motion artifacts in 2 patients at MRI1 (1 in transversal, 1 in coronal plane) and 3 at MRI2 (2 transversal, 1 coronal). The respiratory triggered BLADE showed insufficient image quality in 2 subjects at MRI2 (1 transversal, 1 coronal). The test-retest reliability of image quality scoring of MRI1 vs. MRI2 was moderate with ĸ = 0.41 (95%CI = 0.21–0.60), meaning that image quality may be somewhat variable within the same subject.</p>
</sec>
<sec id="sec027">
<title>Test-retest reliability of MRI in COPD</title>
<p>The median global score for n = 19 patients was 10 (Q1: 8.00; Q3: 16.00) for MRI1 and 11 (Q1: 6.00; Q3: 15.00) for MRI2. The global scores and category subscores were not significantly different between MRI1 and MRI2 (subscore data not shown). We found an “almost perfect” test-retest reliability of MRI1 vs. MRI2 (ĸ = 0.86, 95%CI = 0.81–0.91) (<xref rid="pone.0137282.t003" ref-type="table">Table 3</xref>) based on the entirety of single observations. Kappa statistics indicated “substantial” or “almost perfect” agreement for MRI1 vs. MRI2 with regard to the majority of category subscores (ĸ = 0.64–1.00) (<xref rid="pone.0137282.t003" ref-type="table">Table 3</xref>). For special findings such as atelectasis or pleural effusion (ĸ = 0.42, 95%CI = 0.00–0.93), the agreement for MRI1 vs. MRI2 was “moderate” (<xref rid="pone.0137282.t003" ref-type="table">Table 3</xref>), for tracheal abnormalities (ĸ = 0.21, 95%CI = 0.00–0.75) it was “fair”.</p>
<table-wrap id="pone.0137282.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0137282.t003</object-id>
<label>Table 3</label> <caption><title>Weighted kappa of test vs. retest (consensus of n = 3 readers), displayed for category subscores and for the global score.</title></caption>
<alternatives>
<graphic id="pone.0137282.t003g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0137282.t003" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="1" colspan="1">Category</th>
<th align="left" rowspan="1" colspan="1">κ</th>
<th align="left" rowspan="1" colspan="1">95% CI</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Tracheal disease</td>
<td align="left" rowspan="1" colspan="1">0.21</td>
<td align="left" rowspan="1" colspan="1">0.00–0.75</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Bronchial disease</td>
<td align="left" rowspan="1" colspan="1">0.88</td>
<td align="left" rowspan="1" colspan="1">0.55–0.98</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Small airway disease</td>
<td align="left" rowspan="1" colspan="1">1.00</td>
<td align="left" rowspan="1" colspan="1">1.00–1.00</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Consolidations</td>
<td align="left" rowspan="1" colspan="1">0.80</td>
<td align="left" rowspan="1" colspan="1">0.55–1.00</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Nodules</td>
<td align="left" rowspan="1" colspan="1">0.75</td>
<td align="left" rowspan="1" colspan="1">0.32–1.00</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Parenchymal defects</td>
<td align="left" rowspan="1" colspan="1">0.77</td>
<td align="left" rowspan="1" colspan="1">0.49–1.00</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Perfusion defects</td>
<td align="left" rowspan="1" colspan="1">0.77</td>
<td align="left" rowspan="1" colspan="1">0.61–0.93</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Perfusion defects (collateral findings)</td>
<td align="left" rowspan="1" colspan="1">0.74</td>
<td align="left" rowspan="1" colspan="1">0.24–1.00</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Impaired respiratory mechanics</td>
<td align="left" rowspan="1" colspan="1">0.76</td>
<td align="left" rowspan="1" colspan="1">0.45–1.00</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Impaired respiratory mechanics (collateral findings)</td>
<td align="left" rowspan="1" colspan="1">1.00</td>
<td align="left" rowspan="1" colspan="1">1.00–1.00</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Pulmonary trunk ectasia</td>
<td align="left" rowspan="1" colspan="1">0.86</td>
<td align="left" rowspan="1" colspan="1">0.17–1.00</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Right ventricular enlargement</td>
<td align="left" rowspan="1" colspan="1">0.64</td>
<td align="left" rowspan="1" colspan="1">0.00–1.00</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Special findings</td>
<td align="left" rowspan="1" colspan="1">0.42</td>
<td align="left" rowspan="1" colspan="1">0.00–0.93</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Global</td>
<td align="left" rowspan="1" colspan="1">0.86</td>
<td align="left" rowspan="1" colspan="1">0.81–0.91</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<p>At single patient level, airway abnormalities (<xref rid="pone.0137282.g001" ref-type="fig">Fig 1</xref>), pulmonary consolidations, COPD related-perfusion defects (<xref rid="pone.0137282.g002" ref-type="fig">Fig 2</xref>, <xref rid="pone.0137282.g003" ref-type="fig">Fig 3</xref>), and impairments of respiratory mechanics (collateral findings) were detected in the same number of patients at MRI1 and MRI2 (<xref rid="pone.0137282.t004" ref-type="table">Table 4</xref>). The prevalence of pulmonary nodules was reported slightly higher at MRI1 (37%) than in MRI2 (26%), just as well as the prevalence of special findings (42% vs. 32%). Other categories differed by 1 subject at most between MRI1 and MRI2 (<xref rid="pone.0137282.t004" ref-type="table">Table 4</xref>).</p>
<fig id="pone.0137282.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0137282.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Examples of of typical findings.</title>
<p>(A) Saber sheath trachea in a 69 year old patient diagnosed with GOLD stage IV (“tracheal disease”-score = 1). (B) Complete destruction of the middle lobe due to severe bronchiectasis in a 59 year old patient with GOLD stage II (lobar score for “bronchial disease” = 2). (C) Small airway disease (arrowhead) in the right lower lobe of a 50 year old patient with GOLD stage I (lobar score for the category “small airway disease” = 1). (D) Bronchial carcinoma ≥ 1.0 cm in the right lower lobe adjacent to the bronchovascular bundle of a 79 year old patient with GOLD stage IV (lobar score for the category “nodules” = 2).</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0137282.g001" position="float" xlink:type="simple"/>
</fig>
<fig id="pone.0137282.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0137282.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Discrepancy of parenchymal structure and function in mild COPD.</title>
<p>57 year old male patient suffering from mild COPD (GOLD stage I). VIBE (A), post-contrast VIBE (B), as well as HASTE (C) did not show significant parenchymal alterations. However, functional MRI with 4D first pass perfusion revealed scattered minor defects (arrowheads) across the lung on subtracted images (D) and therefore was rated with a perfusion score of 1 for each lobe.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0137282.g002" position="float" xlink:type="simple"/>
</fig>
<fig id="pone.0137282.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0137282.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Pulmonary emphysema with concomitant perfusion deficit.</title>
<p>Grossly circumscribed structural defect (arrowheads) located in the periphery of the right upper lobe of a 50 year old male patient with GOLD stage I, as displayed on VIBE (A), post-contrast VIBE (B), and HASTE (C). A corresponding, but slightly larger defect (arrowheads) is visible on subtraction images of MR perfusion datasets (D). With regard to the category subscore “parenchymal defects”, the lobe was rated with a score of 1, and with regard to the perfusion score, it was rated with a 2. Additionally, one recognizes a small pleural effusion in the right oblique fissure which is also visible in <xref rid="pone.0137282.g004" ref-type="fig">Fig 4B</xref>.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0137282.g003" position="float" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0137282.t004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0137282.t004</object-id>
<label>Table 4</label> <caption><title>Number of patients with COPD-relevant MRI findings in MRI1 and MRI2 ordered by categories.</title> <p>2 individuals rejected contrast media at each examination.</p></caption>
<alternatives>
<graphic id="pone.0137282.t004g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0137282.t004" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="1" colspan="1">Findings (Category)</th>
<th align="center" rowspan="1" colspan="1">MRI1</th>
<th align="center" rowspan="1" colspan="1">MRI2</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Tracheal disease</td>
<td align="center" rowspan="1" colspan="1">3/19</td>
<td align="center" rowspan="1" colspan="1">3/19</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Bronchial disease</td>
<td align="center" rowspan="1" colspan="1">6/19</td>
<td align="center" rowspan="1" colspan="1">6/19</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Small airway disease</td>
<td align="center" rowspan="1" colspan="1">4/19</td>
<td align="center" rowspan="1" colspan="1">4/19</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Consolidations</td>
<td align="center" rowspan="1" colspan="1">6/19</td>
<td align="center" rowspan="1" colspan="1">6/19</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Nodules</td>
<td align="center" rowspan="1" colspan="1">7/19</td>
<td align="center" rowspan="1" colspan="1">5/19</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Parenchymal defects</td>
<td align="center" rowspan="1" colspan="1">9/19</td>
<td align="center" rowspan="1" colspan="1">10/19</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Perfusion defects</td>
<td align="center" rowspan="1" colspan="1">16/17</td>
<td align="center" rowspan="1" colspan="1">16/17</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Perfusion defects (collateral findings)</td>
<td align="center" rowspan="1" colspan="1">3/17</td>
<td align="center" rowspan="1" colspan="1">4/17</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Impaired respiratory mechanics</td>
<td align="center" rowspan="1" colspan="1">8/19</td>
<td align="center" rowspan="1" colspan="1">9/19</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Impaired respiratory mechanics (collateral findings)</td>
<td align="center" rowspan="1" colspan="1">2/19</td>
<td align="center" rowspan="1" colspan="1">2/19</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Pulmonary trunk ectasia</td>
<td align="center" rowspan="1" colspan="1">5/19</td>
<td align="center" rowspan="1" colspan="1">4/19</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Right ventricular overload</td>
<td align="center" rowspan="1" colspan="1">2/19</td>
<td align="center" rowspan="1" colspan="1">1/19</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Special findings</td>
<td align="center" rowspan="1" colspan="1">8/19</td>
<td align="center" rowspan="1" colspan="1">6/19</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<p>The number of lung lobes with COPD-related findings was relatively stable for most categories from MRI1 through MRI2, as well as their attributed score value (<xref rid="pone.0137282.t005" ref-type="table">Table 5</xref>). Airway categories, consolidations, nodules, collateral perfusion defects, collateral impairments of respiratory mechanics (<xref rid="pone.0137282.g004" ref-type="fig">Fig 4</xref>) and right ventricular enlargement showed similarly low prevalence of up to 16% of lung lobes/chest compartments, mainly with low score values (score = 1) at both timepoints (<xref rid="pone.0137282.t005" ref-type="table">Table 5</xref>). A relatively high number of lung lobes/chest compartments showed parenchymal defects (<xref rid="pone.0137282.g003" ref-type="fig">Fig 3</xref>) based on morphological MRI sequences (26% vs. 33%), perfusion defects (83% vs. 84%) and impaired respiratory mechanics (39% vs. 45%) as well as pulmonary trunk ectasia (26% vs. 21%) at both examinations (<xref rid="pone.0137282.t005" ref-type="table">Table 5</xref>). In particular the number of parenchymal defects seemed to differ between both examinations, with a tendency towards a higher detection rate of minor parenchymal defects at MRI2 (37 vs. 29 lobes), whereas the number of large parenchymal defects remained stable.</p>
<fig id="pone.0137282.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0137282.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Respiratory mechanics in mild and advanced COPD.</title>
<p>Snapshots from dynamic TrueFISP in coronal orientation showing respiratory mechanics in a 50 year old male patient with GOLD stage I (A, B) and a 77 year old male patient with GOLD stage III (C, D). Diaphragmatic function of the patient with mild COPD appeared normal, as shown in inspiration (A) and expiration (B). Note a small pleural effusion in the right oblique fissure as secondary finding (arrowhead). The patient with GOLD stage III showed bilateral phrenic flattening and signs of whipsaw-motion in inspiration (C) and expiration (D). Phrenic motion amplitude was bilaterally restricted, with hardly recognizable motion on the left side (category subscore for respiratory mechanics right = 1; left = 2). Note an emphysemal bulla in the left upper lobe as additional finding.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0137282.g004" position="float" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0137282.t005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0137282.t005</object-id>
<label>Table 5</label> <caption><title>Number of abnormal lung lobes or thoracic compartments as observed on MRI1 or MRI2, ordered by category and by score point (0, 1, or 2 points) for n = 19 patients (n = 114 lobes).</title> <p>Note that the total number of lung lobes for the category perfusion is reduced by 2 patients (12 lobes) who rejected contrast media at each examination.</p></caption>
<alternatives>
<graphic id="pone.0137282.t005g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0137282.t005" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="1" colspan="1"/>
<th colspan="6" align="center" rowspan="1">Number of rated lobes (∑ = 114) / or compartments</th>
<th align="center" rowspan="1" colspan="1"/>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1">Pathology (Category)</th>
<th colspan="2" align="center" rowspan="1">N score = 0</th>
<th colspan="2" align="center" rowspan="1">N score = 1</th>
<th colspan="2" align="center" rowspan="1">N score = 2</th>
<th align="center" rowspan="1" colspan="1">Compartment</th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1"/>
<th align="center" rowspan="1" colspan="1">MRI1</th>
<th align="center" rowspan="1" colspan="1">MRI2</th>
<th align="center" rowspan="1" colspan="1">MRI1</th>
<th align="center" rowspan="1" colspan="1">MRI2</th>
<th align="center" rowspan="1" colspan="1">MRI1</th>
<th align="center" rowspan="1" colspan="1">MRI2</th>
<th align="center" rowspan="1" colspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Tracheal disease</td>
<td align="center" rowspan="1" colspan="1">16</td>
<td align="center" rowspan="1" colspan="1">16</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">Trachea / Stem</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Bronchial disease</td>
<td align="center" rowspan="1" colspan="1">106</td>
<td align="center" rowspan="1" colspan="1">107</td>
<td align="center" rowspan="1" colspan="1">7</td>
<td align="center" rowspan="1" colspan="1">5</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">Lobe</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Small airway disease</td>
<td align="center" rowspan="1" colspan="1">110</td>
<td align="center" rowspan="1" colspan="1">110</td>
<td align="center" rowspan="1" colspan="1">4</td>
<td align="center" rowspan="1" colspan="1">4</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">Lobe</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Consolidations</td>
<td align="center" rowspan="1" colspan="1">108</td>
<td align="center" rowspan="1" colspan="1">107</td>
<td align="center" rowspan="1" colspan="1">5</td>
<td align="center" rowspan="1" colspan="1">5</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">Lobe</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Nodules</td>
<td align="center" rowspan="1" colspan="1">104</td>
<td align="center" rowspan="1" colspan="1">106</td>
<td align="center" rowspan="1" colspan="1">8</td>
<td align="center" rowspan="1" colspan="1">6</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">Lobe</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Parenchymal defects</td>
<td align="center" rowspan="1" colspan="1">84</td>
<td align="center" rowspan="1" colspan="1">76</td>
<td align="center" rowspan="1" colspan="1">29</td>
<td align="center" rowspan="1" colspan="1">37</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">Lobe</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Perfusion defects (102 lobes)</td>
<td align="center" rowspan="1" colspan="1">17</td>
<td align="center" rowspan="1" colspan="1">16</td>
<td align="center" rowspan="1" colspan="1">49</td>
<td align="center" rowspan="1" colspan="1">46</td>
<td align="center" rowspan="1" colspan="1">36</td>
<td align="center" rowspan="1" colspan="1">40</td>
<td align="center" rowspan="1" colspan="1">Lobe</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Perfusion defects (collateral findings, 102 lobes)</td>
<td align="center" rowspan="1" colspan="1">99</td>
<td align="center" rowspan="1" colspan="1">98</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">Lobe</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Impaired respiratory mechanics</td>
<td align="center" rowspan="1" colspan="1">23</td>
<td align="center" rowspan="1" colspan="1">21</td>
<td align="center" rowspan="1" colspan="1">13</td>
<td align="center" rowspan="1" colspan="1">14</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">Chest r/l</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Impaired respiratory mechanics (collateral findings)</td>
<td align="center" rowspan="1" colspan="1">36</td>
<td align="center" rowspan="1" colspan="1">36</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">Chest r/l</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Pulmonary trunk ectasia</td>
<td align="center" rowspan="1" colspan="1">14</td>
<td align="center" rowspan="1" colspan="1">15</td>
<td align="center" rowspan="1" colspan="1">5</td>
<td align="center" rowspan="1" colspan="1">4</td>
<td align="center" rowspan="1" colspan="1"/>
<td align="center" rowspan="1" colspan="1"/>
<td align="center" rowspan="1" colspan="1">Pulm. trunk</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Right ventricular enlargement</td>
<td align="center" rowspan="1" colspan="1">17</td>
<td align="center" rowspan="1" colspan="1">18</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1"/>
<td align="center" rowspan="1" colspan="1"/>
<td align="center" rowspan="1" colspan="1">Heart</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Special findings</td>
<td align="center" rowspan="1" colspan="1">29</td>
<td align="center" rowspan="1" colspan="1">32</td>
<td align="center" rowspan="1" colspan="1">9</td>
<td align="center" rowspan="1" colspan="1">6</td>
<td align="center" rowspan="1" colspan="1"/>
<td align="center" rowspan="1" colspan="1"/>
<td align="center" rowspan="1" colspan="1">Chest r/l</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
</sec>
</sec>
<sec id="sec028" sec-type="conclusions">
<title>Discussion</title>
<p>The aim of the study was the assessment the test-retest reliability of a combined morpho-functional MRI protocol based on commercially available sequences for COPD-related regional abnormalities of lung structure, perfusion, and respiratory mechanics as well as pulmonary hypertension. Continuously high image quality is a prerequisite for this concept, since insufficient or varying image quality decreases reproducibility with significant influence on image-based quantitative or semiquantitative biomarkers. Many patients with severe COPD are short of breath and thus unable to comply with long breath-holding times. Image quality is therefore frequently limited. Gay et al. reported a maximum breath-holding time of 25 seconds during CT imaging of patients with COPD, chronic heart failure or extensive smoking history and 45 seconds in patients without pulmonary disease [<xref rid="pone.0137282.ref023" ref-type="bibr">23</xref>]. To meet the requirements for scanning COPD patients, the protocol employed respiratory triggered and free breathing sequences which are less stressful for the patient and reduce or eliminate the influence of respiratory motion. Breath-holding times of most sequences were below 25 seconds with few exceptions: The 4D perfusion sequence (TWIST) covered a time period of 37 seconds since circulation times are difficult to predict in morbid patients and frequently prolonged. However, observed individual abilities of COPD patients to hold breath were sufficient for artifact-free perfusion acquisition during the first pulmonary passage of the contrast bolus (15–25s). The fat-saturated VIBEs were the only morphological acquisitions exceeding breath-holding times of 25 seconds. In general, the imaging protocol proved to be robust since image quality was at least diagnostic at both examinations, with only few fat-saturated VIBEs and BLADE acquisitions in different patients showing insufficient image quality. This may be partially due to the prolonged breath-holding time of fat-saturated VIBE, but advances in parallel imaging will certainly allow for a reduction of fat-saturated VIBE acquisition times in the near future. Although most MRI data sets showed a high level of image quality, the test-retest reliability of image quality scoring of MRI1 vs. MRI2 was only moderate with ĸ = 0.41. This reflects intra-subject fluctuations of image quality related to image artifacts of insignificant extent, mainly minor respiratory motion, cardiac motion, and in some cases, Gibbs ringing artifacts. Furthermore, the 4D DCE perfusion sequence and the contrast regimen were also designed to meet the requirements of a software-based calculation of regional quantitative perfusion parameters. The designed MRI protocol also met the expectations concerning test-retest reliability, since COPD-related lung abnormalities were depicted with “almost perfect” reproducibility within 1 day. For imaging-based phenotyping of COPD, the extent of airway remodeling and pulmonary emphysema would need to be systematically assessed [<xref rid="pone.0137282.ref024" ref-type="bibr">24</xref>]. Today, CT is the modality of choice for in vivo imaging of the pulmonary parenchyma and airways in COPD [<xref rid="pone.0137282.ref002" ref-type="bibr">2</xref>,<xref rid="pone.0137282.ref025" ref-type="bibr">25</xref>]. MRI of the lung remains challenging due to low proton density and thus low MRI signal of lung tissue. Spatial resolution of MRI is inferior to CT in the order of 2 to 4 times, thus affecting airway imaging which can be performed down to the segmental level in healthy individuals. However, bronchial wall thickening and dilatation increase visibility on MRI and improve the specificity of MRI for airway pathology. Furthermore, small airways disease with tree-in-bud pattern is also sensitively depicted by MRI [<xref rid="pone.0137282.ref006" ref-type="bibr">6</xref>,<xref rid="pone.0137282.ref026" ref-type="bibr">26</xref>]. The present study is the first of its kind to systematically evaluate airway alterations in COPD patients with MRI. Airway pathologies were found in approximately half of the patients in both MR examinations. However, the number of affected lung lobes was infrequent at both time points. Kappa statistics indicated “almost perfect” reproducibility for abnormalities of large and small airways. The evaluation of tracheal abnormalities showed a “fair” agreement between MRI1 and MRI2, reflecting reduced test-retest reliability compared to other subscore categories. This might be based on the fact that the evaluation of tracheal narrowing was based on the combined evaluation of free-breathing, respiratory-triggered and inspiratory breath-hold acquisitions which comes close to but obviously cannot replace dynamic acquisitions during forced inspiration/expiration and free breathing. In patients with COPD, the additional loss of signal due to emphysematous destruction, hyperinflation and hypoxic pulmonary vasoconstriction deteriorates conditions for structural <sup>1</sup>H-MRI [<xref rid="pone.0137282.ref027" ref-type="bibr">27</xref>,<xref rid="pone.0137282.ref028" ref-type="bibr">28</xref>]. In the present study, parenchymal defects based on morphological MR images were detected in a substantial number of lung lobes at both MRI1 and MRI2 (26% vs. 33%) with “substantial” agreement between both examinations. Ley-Zaporozhan et al. compared MRI-based and CT-based emphysema classification and reported that the extent of emphysema was rated correctly using morphological MRI sequences in 63% of lung lobes, suggesting that emphysema characterization with structural MRI is less sensitive than with CT, but provides a certain impression of emphysema severity [<xref rid="pone.0137282.ref014" ref-type="bibr">14</xref>]. Moreover, the protocol was aimed to cover frequent COPD-related inflammatory or potentially malignant comorbidities such as pneumonia and pulmonary nodules, which should not be missed in cross-sectional imaging of the lung. These findings had a low prevalence in our population but were depicted with high (“substantial”) test-retest reproducibility. This is perfectly in keep with recently published results on lung nodule detection in a lung cancer CT screening population by Sommer et al., who could show that the inter-rater variability for lung nodules was only 84% with κ = 0.65 with a similar morphological protocol but without contrast application [<xref rid="pone.0137282.ref029" ref-type="bibr">29</xref>]. In COPD patients, perfusion can be adversely affected by hypoxic pulmonary vasoconstriction, remodeling or rarefication of the pulmonary vasculature due to tissue destruction [<xref rid="pone.0137282.ref030" ref-type="bibr">30</xref>]. MRI is capable of depicting such perfusion abnormalities with similar sensitivity and specificity as pulmonary radionuclide scintigraphy [<xref rid="pone.0137282.ref031" ref-type="bibr">31</xref>]. Moreover, Ley-Zaporozhan et al. reported a high sensitivity of MR perfusion imaging for emphysematous lung areas visible on CT [<xref rid="pone.0137282.ref032" ref-type="bibr">32</xref>]. However, contrast enhanced MR perfusion has been shown to be an appropriate surrogate parameter for both, parenchymal destruction and airway obstruction [<xref rid="pone.0137282.ref033" ref-type="bibr">33</xref>–<xref rid="pone.0137282.ref035" ref-type="bibr">35</xref>]. The 4D DCE perfusion study employed for the present study demonstrated “substantial” test-retest reproducibility concerning the presence, localization and extent of lung areas with reduced perfused blood volume. Additionally, it revealed a high prevalence of lung areas with reduced blood content per volume at both timepoints (86% vs. 88%). It is well known that advanced hyperinflation and emphysema in COPD affect chest wall and diaphragmatic motion [<xref rid="pone.0137282.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0137282.ref017" ref-type="bibr">17</xref>] leading to reduced extent of motion and/or paradoxical movement, which has been studied by 4DCT [<xref rid="pone.0137282.ref036" ref-type="bibr">36</xref>] as well as time-resolved MRI acquisitions [<xref rid="pone.0137282.ref015" ref-type="bibr">15</xref>,<xref rid="pone.0137282.ref017" ref-type="bibr">17</xref>]. Image-based evaluation of respiratory mechanics is of potential value for patient monitoring in the context of interventions such as lung volume reduction surgery, which are believed to improve lung function through respiratory mechanics [<xref rid="pone.0137282.ref037" ref-type="bibr">37</xref>]. However, the reproducibility of findings in dynamic TrueFISP during maximum inspiration and expiration has not been assessed yet. Dynamic TrueFISP sequences during maximum inspiration and expiration revealed respiratory motion impairment in the same number of chest compartments at MRI1 and MRI2 (each 17/38) with similar extent of severity. In this context, extensive motivation and guidance of the patients ensured high test-retest reliability. Morphological indicators of pulmonary hypertension were detected with high reproducibility, in detail right ventricular enlargement and pulmonary trunk ectasia, thereby providing information on the probability of severe exacerbations [<xref rid="pone.0137282.ref038" ref-type="bibr">38</xref>] and 5-year survival rate [<xref rid="pone.0137282.ref039" ref-type="bibr">39</xref>]. Pathologies addressed by the category “special findings” (which entailed mainly small atelectasis and minor pleural effusion) are per se highly variable throughout 24 hours. As a result, kappa statistics indicated moderate test-retest reliability for this category, which should not be attributed to MRI. In the near future, new MRI techniques based on near zero echo times such as ultra-short echo time (UTE) sequences will improve image quality of proton MRI of the lung, providing higher spatial resolution, better signal-to-noise ratio and shorter scan time [<xref rid="pone.0137282.ref040" ref-type="bibr">40</xref>, <xref rid="pone.0137282.ref041" ref-type="bibr">41</xref>]. Most clinical scanner vendors already offer UTE sequences for selected MRI devices, in many cases as work in progress (WIP) sequences. First experiences in subjects with cystic fibrosis [<xref rid="pone.0137282.ref042" ref-type="bibr">42</xref>] indicate the high potential of these techniques in the evaluation of pulmonary structure and function in subjects with lung diseases. The proposed imaging protocol will be the basis of a prospective study (DRKS00005072) comparing the performance of MRI- with CT-based phenotyping of COPD in a large multicenter subcohort of the German COPD cohort (Impact of Systemic Manifestations/Comorbidities on Clinical State, Prognosis, Utilisation of Health Care Resources in Patients with COPD study “COSYCONET”, NCT01245933).</p>
</sec>
<sec id="sec029" sec-type="conclusions">
<title>Conclusion</title>
<p>The proposed imaging protocol allowed for the evaluation of COPD-related alterations of bronchi, pulmonary parenchyma, perfusion, and respiratory mechanics with high test-retest reliability. Even in patients with advanced COPD, image quality of most acquisitions was at least diagnostic at both examinations. The proposed imaging protocol appears valuable for phenotyping COPD as well as monitoring of regional lung structure and function in clinical trials.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="pone.0137282.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Han</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Agusti</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Calverley</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Celli</surname> <given-names>BR</given-names></name>, <name name-style="western"><surname>Criner</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Curtis</surname> <given-names>JL</given-names></name>, <etal>et al</etal>. <article-title>Chronic obstructive pulmonary disease phenotypes: the future of COPD</article-title>. <source>Am J Respir Crit Care Med</source> <year>2010</year>; <volume>182</volume>: <fpage>598</fpage>–<lpage>604</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1164/rccm.200912-1843CC" xlink:type="simple">10.1164/rccm.200912-1843CC</ext-link></comment> <object-id pub-id-type="pmid">20522794</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Coxson</surname> <given-names>HO</given-names></name>, <name name-style="western"><surname>Rogers</surname> <given-names>RM</given-names></name>. <article-title>Quantitative computed tomography of chronic obstructive pulmonary disease</article-title>. <source>Acad Radiol</source> <year>2005</year>; <volume>12</volume>: <fpage>1457</fpage>–<lpage>1463</lpage>. <object-id pub-id-type="pmid">16253858</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Coxson</surname> <given-names>HO</given-names></name>. <article-title>Quantitative computed tomography assessment of airway wall dimensions: current status and potential applications for phenotyping chronic obstructive pulmonary disease</article-title>. <source>Proc Am Thorac Soc</source> <year>2008</year>; <volume>5</volume>: <fpage>940</fpage>–<lpage>945</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1513/pats.200806-057QC" xlink:type="simple">10.1513/pats.200806-057QC</ext-link></comment> <object-id pub-id-type="pmid">19056721</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Biederer</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Mirsadraee</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Beer</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Molinari</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Hintze</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Bauman</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>MRI of the lung (3/3)-current applications and future perspectives</article-title>. <source>Insights Imaging</source> <year>2012</year>; <volume>3</volume>: <fpage>373</fpage>–<lpage>386</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s13244-011-0142-z" xlink:type="simple">10.1007/s13244-011-0142-z</ext-link></comment> <object-id pub-id-type="pmid">22695943</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ley-Zaporozhan</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>van Beek</surname> <given-names>EJ</given-names></name>. <article-title>Imaging phenotypes of chronic obstructive pulmonary disease</article-title>. <source>J Magn Reson Imaging</source> <year>2010</year>; <volume>32</volume>: <fpage>1340</fpage>–<lpage>1352</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/jmri.22376" xlink:type="simple">10.1002/jmri.22376</ext-link></comment> <object-id pub-id-type="pmid">21105139</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wielputz</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kauczor</surname> <given-names>HU</given-names></name>. <article-title>MRI of the lung: state of the art</article-title>. <source>Diagn Interv Radiol</source> <year>2012</year>; <volume>18</volume>: <fpage>344</fpage>–<lpage>353</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4261/1305-3825.DIR.5365-11.0" xlink:type="simple">10.4261/1305-3825.DIR.5365-11.0</ext-link></comment> <object-id pub-id-type="pmid">22434450</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Biederer</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Beer</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hirsch</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Wild</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Fabel</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Puderbach</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>MRI of the lung (2/3). Why… when… how?</article-title> <source>Insights Imaging</source> <year>2012</year>; <volume>3</volume>: <fpage>355</fpage>–<lpage>371</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s13244-011-0146-8" xlink:type="simple">10.1007/s13244-011-0146-8</ext-link></comment> <object-id pub-id-type="pmid">22695944</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wielputz</surname> <given-names>MO</given-names></name>, <name name-style="western"><surname>Puderbach</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kopp-Schneider</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Stahl</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Fritzsching</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Sommerburg</surname> <given-names>O</given-names></name>, <etal>et al</etal>. <article-title>Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease</article-title>. <source>Am J Respir Crit Care Med</source> <year>2014</year>; <volume>189</volume>: <fpage>956</fpage>–<lpage>965</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1164/rccm.201309-1659OC" xlink:type="simple">10.1164/rccm.201309-1659OC</ext-link></comment> <object-id pub-id-type="pmid">24564281</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fan</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Xia</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Guan</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>TF</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>SY</given-names></name>, <etal>et al</etal>. <article-title>Capability of differentiating smokers with normal pulmonary function from COPD patients: a comparison of CT pulmonary volume analysis and MR perfusion imaging</article-title>. <source>Eur Radiol</source> <year>2013</year>; <volume>23</volume>: <fpage>1234</fpage>–<lpage>1241</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00330-012-2729-2" xlink:type="simple">10.1007/s00330-012-2729-2</ext-link></comment> <object-id pub-id-type="pmid">23263604</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xia</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Guan</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Fan</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>SY</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>LM</given-names></name>, <etal>et al</etal>. <article-title>Dynamic Contrast Enhanced Magnetic Resonance Perfusion Imaging in High-Risk Smokers and Smoking-Related COPD: Correlations with Pulmonary Function Tests and Quantitative Computed Tomography</article-title>. <source>COPD</source> <year>2014</year>; <volume>11</volume>: <fpage>510</fpage>–<lpage>520</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3109/15412555.2014.948990" xlink:type="simple">10.3109/15412555.2014.948990</ext-link></comment> <object-id pub-id-type="pmid">25211632</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hueper</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Parikh</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Prince</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>Schoenfeld</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Bluemke</surname> <given-names>DA</given-names></name>, <etal>et al</etal>. <article-title>Quantitative and semiquantitative measures of regional pulmonary microvascular perfusion by magnetic resonance imaging and their relationships to global lung perfusion and lung diffusing capacity: the multiethnic study of atherosclerosis chronic obstructive pulmonary disease study</article-title>. <source>Invest Radiol</source> <year>2013</year>; <volume>48</volume>: <fpage>223</fpage>–<lpage>230</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/RLI.0b013e318281057d" xlink:type="simple">10.1097/RLI.0b013e318281057d</ext-link></comment> <object-id pub-id-type="pmid">23385398</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rabe</surname> <given-names>KF</given-names></name>, <name name-style="western"><surname>Hurd</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Anzueto</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Barnes</surname> <given-names>PJ</given-names></name>, <name name-style="western"><surname>Buist</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Calverley</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary</article-title>. <source>Am J Respir Crit Care Med</source> <year>2007</year>; <volume>176</volume>: <fpage>532</fpage>–<lpage>555</lpage>. <object-id pub-id-type="pmid">17507545</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eichinger</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Optazaite</surname> <given-names>DE</given-names></name>, <name name-style="western"><surname>Kopp-Schneider</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hintze</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Biederer</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Niemann</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Morphologic and functional scoring of cystic fibrosis lung disease using MRI</article-title>. <source>Eur J Radiol</source> <year>2012</year>; <volume>81</volume>: <fpage>1321</fpage>–<lpage>1329</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ejrad.2011.02.045" xlink:type="simple">10.1016/j.ejrad.2011.02.045</ext-link></comment> <object-id pub-id-type="pmid">21429685</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ley-Zaporozhan</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Ley</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Eberhardt</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Kauczor</surname> <given-names>HU</given-names></name>, <name name-style="western"><surname>Heussel</surname> <given-names>CP</given-names></name>. <article-title>Visualization of morphological parenchymal changes in emphysema: comparison of different MRI sequences to 3D-HRCT</article-title>. <source>Eur J Radiol</source> <year>2010</year>; <volume>73</volume>: <fpage>43</fpage>–<lpage>49</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ejrad.2008.09.029" xlink:type="simple">10.1016/j.ejrad.2008.09.029</ext-link></comment> <object-id pub-id-type="pmid">18995980</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Suga</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Tsukuda</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Awaya</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Takano</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Koike</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Matsunaga</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Impaired respiratory mechanics in pulmonary emphysema: evaluation with dynamic breathing MRI</article-title>. <source>J Magn Reson Imaging</source> <year>1999</year>; <volume>10</volume>: <fpage>510</fpage>–<lpage>520</lpage>. <object-id pub-id-type="pmid">10508317</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Iwasawa</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Yoshiike</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Saito</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kagei</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Gotoh</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Matsubara</surname> <given-names>S</given-names></name>. <article-title>Paradoxical motion of the hemidiaphragm in patients with emphysema</article-title>. <source>J Thorac Imaging</source> <year>2000</year>; <volume>15</volume>: <fpage>191</fpage>–<lpage>195</lpage>. <object-id pub-id-type="pmid">10928612</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Iwasawa</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Kagei</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Gotoh</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Yoshiike</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Matsushita</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kurihara</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Magnetic resonance analysis of abnormal diaphragmatic motion in patients with emphysema</article-title>. <source>Eur Respir J</source> <year>2002</year>; <volume>19</volume>: <fpage>225</fpage>–<lpage>231</lpage>. <object-id pub-id-type="pmid">11866002</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tan</surname> <given-names>RT</given-names></name>, <name name-style="western"><surname>Kuzo</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Goodman</surname> <given-names>LR</given-names></name>, <name name-style="western"><surname>Siegel</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Haasler</surname> <given-names>GB</given-names></name>, <name name-style="western"><surname>Presberg</surname> <given-names>KW</given-names></name>. <article-title>Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease</article-title>. <source>Medical College of Wisconsin Lung Transplant Group. Chest</source> <year>1998</year>; <volume>113</volume>: <fpage>1250</fpage>–<lpage>1256</lpage>.</mixed-citation></ref>
<ref id="pone.0137282.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Van der Meer</surname> <given-names>RW</given-names></name>, <name name-style="western"><surname>Pattynama</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>van Strijen</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>van den Berg-Huijsmans</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Hartmann</surname> <given-names>IJ</given-names></name>, <name name-style="western"><surname>Putter</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Right ventricular dysfunction and pulmonary obstruction index at helical CT: prediction of clinical outcome during 3-month follow-up in patients with acute pulmonary embolism</article-title>. <source>Radiology</source> <year>2005</year>; <volume>235</volume>: <fpage>798</fpage>–<lpage>803</lpage>. <object-id pub-id-type="pmid">15845793</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cohen</surname> <given-names>J</given-names></name>. <article-title>Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit</article-title>. <source>Psychol Bull</source> <year>1968</year>; <volume>70</volume>: <fpage>213</fpage>–<lpage>220</lpage>. <object-id pub-id-type="pmid">19673146</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cohen</surname> <given-names>J</given-names></name>. <article-title>A coefficient of agreement for nominal scales</article-title>. <source>Educational and Psychological Measurement</source> <year>1960</year>; <volume>20</volume>: <fpage>37</fpage>–<lpage>46</lpage>.</mixed-citation></ref>
<ref id="pone.0137282.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Landis</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Koch</surname> <given-names>GG</given-names></name>. <article-title>The measurement of observer agreement for categorical data</article-title>. <source>Biometrics</source> <year>1977</year>; <volume>33</volume>: <fpage>159</fpage>–<lpage>174</lpage>. <object-id pub-id-type="pmid">843571</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gay</surname> <given-names>SB</given-names></name>, <name name-style="western"><surname>Sistrom</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>Holder</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Suratt</surname> <given-names>PM</given-names></name>. <article-title>Breath-holding capability of adults. Implications for spiral computed tomography, fast-acquisition magnetic resonance imaging, and angiography</article-title>. <source>Invest Radiol</source> <year>1994</year>; <volume>29</volume>: <fpage>848</fpage>–<lpage>851</lpage>. <object-id pub-id-type="pmid">7995705</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lynch</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Austin</surname> <given-names>JHM</given-names></name>, <name name-style="western"><surname>Hogg</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Grenier</surname> <given-names>PA</given-names></name>, <name name-style="western"><surname>Kauczor</surname> <given-names>HU</given-names></name>, <name name-style="western"><surname>Bankier</surname> <given-names>AA</given-names></name>, <etal>et al</etal>. <article-title>CT definable subtypes of COPD: a statement of the Fleischner Society</article-title>. <source>Radiology</source>, in press.</mixed-citation></ref>
<ref id="pone.0137282.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kauczor</surname> <given-names>HU</given-names></name>, <name name-style="western"><surname>Wielputz</surname> <given-names>MO</given-names></name>, <name name-style="western"><surname>Owsijewitsch</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ley-Zaporozhan</surname> <given-names>J</given-names></name>. <article-title>Computed tomographic imaging of the airways in COPD and asthma</article-title>. <source>J Thorac Imaging</source> <year>2011</year>; <volume>26</volume>: <fpage>290</fpage>–<lpage>300</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/RTI.0b013e3182277113" xlink:type="simple">10.1097/RTI.0b013e3182277113</ext-link></comment> <object-id pub-id-type="pmid">22009082</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Puderbach</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Eichinger</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Haeselbarth</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Ley</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kopp-Schneider</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Tuengerthal</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Assessment of morphological MRI for pulmonary changes in cystic fibrosis (CF) patients: comparison to thin-section CT and chest x-ray</article-title>. <source>Invest Radiol</source> <year>2007</year>; <volume>42</volume>: <fpage>715</fpage>–<lpage>725</lpage>. <object-id pub-id-type="pmid">17984769</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Puderbach</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Eichinger</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Gahr</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Ley</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tuengerthal</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Schmahl</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Proton MRI appearance of cystic fibrosis: comparison to CT</article-title>. <source>Eur Radiol</source> <year>2007</year>; <volume>17</volume>: <fpage>716</fpage>–<lpage>724</lpage>. <object-id pub-id-type="pmid">16941092</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ley-Zaporozhan</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Puderbach</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kauczor</surname> <given-names>HU</given-names></name>. <article-title>MR for the evaluation of obstructive pulmonary disease</article-title>. <source>Magn Reson Imaging Clin N Am</source> <year>2008</year>; <volume>16</volume>: <fpage>291</fpage>–<lpage>308</lpage>, ix. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.mric.2008.02.014" xlink:type="simple">10.1016/j.mric.2008.02.014</ext-link></comment> <object-id pub-id-type="pmid">18474333</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sommer</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Tremper</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Koenigkam-Santos</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Delorme</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Becker</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Biederer</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Lung nodule detection in a high-risk population: comparison of magnetic resonance imaging and low-dose computed tomography</article-title>. <source>Eur J Radiol</source> <year>2014</year>; <volume>83</volume>: <fpage>600</fpage>–<lpage>605</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ejrad.2013.11.012" xlink:type="simple">10.1016/j.ejrad.2013.11.012</ext-link></comment> <object-id pub-id-type="pmid">24364923</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barr</surname> <given-names>RG</given-names></name>. <article-title>The epidemiology of vascular dysfunction relating to chronic obstructive pulmonary disease and emphysema</article-title>. <source>Proc Am Thorac Soc</source> <year>2011</year>; <volume>8</volume>: <fpage>522</fpage>–<lpage>527</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1513/pats.201101-008MW" xlink:type="simple">10.1513/pats.201101-008MW</ext-link></comment> <object-id pub-id-type="pmid">22052931</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sergiacomi</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Sodani</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Fabiano</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Manenti</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Spinelli</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Konda</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>MRI lung perfusion 2D dynamic breath-hold technique in patients with severe emphysema</article-title>. <source>In Vivo</source> <year>2003</year>; <volume>17</volume>: <fpage>319</fpage>–<lpage>324</lpage>. <object-id pub-id-type="pmid">12929586</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ley-Zaporozhan</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Ley</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Eberhardt</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Weinheimer</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Fink</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Puderbach</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Assessment of the relationship between lung parenchymal destruction and impaired pulmonary perfusion on a lobar level in patients with emphysema</article-title>. <source>Eur J Radiol</source> <year>2007</year>; <volume>63</volume>: <fpage>76</fpage>–<lpage>83</lpage>. <object-id pub-id-type="pmid">17320333</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eichinger</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Puderbach</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Fink</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Gahr</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Ley</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Plathow</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Contrast-enhanced 3D MRI of lung perfusion in children with cystic fibrosis—initial results</article-title>. <source>Eur Radiol</source> <year>2006</year>; <volume>16</volume>: <fpage>2147</fpage>–<lpage>2152</lpage>. <object-id pub-id-type="pmid">16673092</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thieme</surname> <given-names>SF</given-names></name>, <name name-style="western"><surname>Graute</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Nikolaou</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Maxien</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Reiser</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>Hacker</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Dual Energy CT lung perfusion imaging—correlation with SPECT/CT</article-title>. <source>Eur J Radiol</source> <year>2012</year>; <volume>81</volume>: <fpage>360</fpage>–<lpage>365</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ejrad.2010.11.037" xlink:type="simple">10.1016/j.ejrad.2010.11.037</ext-link></comment> <object-id pub-id-type="pmid">21185141</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hopkins</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>Wielputz</surname> <given-names>MO</given-names></name>, <name name-style="western"><surname>Kauczor</surname> <given-names>HU</given-names></name>. <article-title>Imaging lung perfusion</article-title>. <source>J Appl Physiol</source> <year>2012</year>; <volume>113</volume>: <fpage>328</fpage>–<lpage>339</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1152/japplphysiol.00320.2012" xlink:type="simple">10.1152/japplphysiol.00320.2012</ext-link></comment> <object-id pub-id-type="pmid">22604884</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wielputz</surname> <given-names>MO</given-names></name>, <name name-style="western"><surname>Eberhardt</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Puderbach</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Weinheimer</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Kauczor</surname> <given-names>HU</given-names></name>, <name name-style="western"><surname>Heussel</surname> <given-names>CP</given-names></name>. <article-title>Simultaneous assessment of airway instability and respiratory dynamics with low-dose 4D-CT in chronic obstructive pulmonary disease: a technical note</article-title>. <source>Respiration</source> <year>2014</year>; <volume>87</volume>: <fpage>294</fpage>–<lpage>300</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1159/000357448" xlink:type="simple">10.1159/000357448</ext-link></comment> <object-id pub-id-type="pmid">24557362</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Henderson</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Ingenito</surname> <given-names>EP</given-names></name>, <name name-style="western"><surname>Salcedo</surname> <given-names>ES</given-names></name>, <name name-style="western"><surname>Moy</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Reilly</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Lutchen</surname> <given-names>KR</given-names></name>. <article-title>Dynamic lung mechanics in late-stage emphysema before and after lung volume reduction surgery</article-title>. <source>Respir Physiol Neurobiol</source> <year>2007</year>; <volume>155</volume>: <fpage>234</fpage>–<lpage>242</lpage>. <object-id pub-id-type="pmid">16870511</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wells</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Washko</surname> <given-names>GR</given-names></name>, <name name-style="western"><surname>Han</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Abbas</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Nath</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Mamary</surname> <given-names>AJ</given-names></name>, <etal>et al</etal>. <article-title>Pulmonary arterial enlargement and acute exacerbations of COPD</article-title>. <source>N Engl J Med</source> <year>2012</year>; <volume>367</volume>: <fpage>913</fpage>–<lpage>921</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa1203830" xlink:type="simple">10.1056/NEJMoa1203830</ext-link></comment> <object-id pub-id-type="pmid">22938715</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Oswald-Mammosser</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Weitzenblum</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Quoix</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Moser</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Chaouat</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Charpentier</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure</article-title>. <source>Chest</source> <year>1995</year>; <volume>107</volume>: <fpage>1193</fpage>–<lpage>1198</lpage>. <object-id pub-id-type="pmid">7750305</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Johnson</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Fain</surname> <given-names>SB</given-names></name>, <name name-style="western"><surname>Schiebler</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Nagle</surname> <given-names>S</given-names></name>. <article-title>Optimized 3d ultrashort echo time pulmonary mri. Magnetic resonance in medicine: official journal of the Society of Magnetic Resonance in Medicine /</article-title> <source>Society of Magnetic Resonance in Medicine</source> <year>2013</year>; <volume>70</volume>: <fpage>1241</fpage>–<lpage>1250</lpage>.</mixed-citation></ref>
<ref id="pone.0137282.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miller</surname> <given-names>GW</given-names></name>, <name name-style="western"><surname>Mugler</surname> <given-names>JP</given-names> <suffix>3rd</suffix></name>, <name name-style="western"><surname>Sa</surname> <given-names>RC</given-names></name>, <name name-style="western"><surname>Altes</surname> <given-names>TA</given-names></name>, <name name-style="western"><surname>Prisk</surname> <given-names>GK</given-names></name>, <name name-style="western"><surname>Hopkins</surname> <given-names>SR</given-names></name>. <article-title>Advances in functional and structural imaging of the human lung using proton mri</article-title>. <source>NMR in biomedicine</source> <year>2014</year>; <volume>27</volume>: <fpage>1542</fpage>–<lpage>1556</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/nbm.3156" xlink:type="simple">10.1002/nbm.3156</ext-link></comment> <object-id pub-id-type="pmid">24990096</object-id></mixed-citation></ref>
<ref id="pone.0137282.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dournes</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Grodzki</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Macey</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Girodet</surname> <given-names>PO</given-names></name>, <name name-style="western"><surname>Fayon</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Chateil</surname> <given-names>JF</given-names></name> <etal>et al</etal>. <article-title>Quiet submillimeter mr imaging of the lung is feasible with a petra sequence at 1.5 t</article-title>. <source>Radiology</source> <year>2015</year>; <volume>276</volume>: <fpage>258</fpage>–<lpage>265</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1148/radiol.15141655" xlink:type="simple">10.1148/radiol.15141655</ext-link></comment> <object-id pub-id-type="pmid">25768672</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>